Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 21, 2026

  1. Notable: Albumin Therapy in Mechanically Ventilated · Sepsis-Associated ARDS Start date pushed from Oct 10, 2026 to Nov 20, 2026 The Second Affiliated Hospital of Hainan Medical UniversityNot specified NCT07857928
  2. Notable: Mechanical Modalities Combined With Standard Therapy Versus Standard Therapy Alone for Edema and Pain Management After Distal Radius Fracture Fixation Primary completion date changed from estimate of Jan 15, 2026 to Oct 28, 2026 Al Hayah University In CairoNot applicable NCT06913920
  3. Notable: Ultra-high-performance Positron Emission Tomography (PET) of Synaptic Density, Reactive Astrogliosis and Tau in Alzheimer's Disease Start date pushed from Oct 2026 to Dec 2026 Universitaire Ziekenhuizen KU LeuvenNot specified NCT07906054
  4. Notable: Meal Sequence and Eating Speed on Blood Glucose After Eating Western Breakfast Among Healthy Young Adults Eligibility criteria changed University of Veterinary and Animal Sciences, Lahore - PakistanNot applicable NCT07932769
  5. Notable: Light Timing Study Results posted: Nov 17, 2026 Rush University Medical CenterNot applicable NCT04753190
  6. Notable: Pelvic Floor Ultrasound Before Induction of Labour and Labour Outcome Start date pushed from Oct 1, 2026 to Dec 1, 2026 University of Roma La SapienzaNot specified NCT07797387
  7. Notable: Prevention of Edema After Coronary Artery Bypass Graft by Customized Pressure-guided Elastic Bandages Primary completion date changed from estimate of Mar 31, 2026 to Nov 16, 2026 Siriraj HospitalNot applicable NCT06603961
  8. Notable: Real-World Study Comparing PCSK9 Monoclonal Antibody With Cholesterol Absorption Inhibitors · ASCVD for Secondary Prevention Eligibility criteria changed Xin LiNot specified NCT07938099
  9. Notable: Subclinical Renal Dysfunction in Rheumatoid Arthritis Start date pushed from Sep 1, 2026 to Nov 20, 2026 Assiut UniversityNot specified NCT07805109
  10. Notable: Designing a Spatial Navigation Intervention Protocol Informed by Region-specific Brain Activation for Mild Cognitive Impairment Eligibility criteria changed Albert Einstein College of MedicineNot applicable NCT07225400
  11. Notable: Digital ACT Psychological Support for Primary Caregivers · Severe Mental Illness Eligibility criteria changed Harbin Medical UniversityNot applicable NCT07931872
  12. Notable: Flavored Ready-to-Drink Alcohol Restriction in Young Adults: Behavioral and Biomarker Outcomes Start date pushed from Oct 2026 to Jan 2027 Medical University of South CarolinaNot applicable NCT07840625
  13. Notable: Prenatal Education on Environmental Exposures During Pregnancy Study (PEEPS) Start date pushed from Aug 27, 2026 to Sep 27, 2026 The University of Texas Medical Branch, GalvestonNot applicable NCT07758114
  14. Notable: Touch Methods on Pain and Physiological Parameters in Preterm Infants During Endotracheal Aspiration Primary completion date changed from estimate of Jul 1, 2025 to Jan 2, 2026 Acibadem UniversityNot applicable NCT05784857
  15. Notable: Confidence-Building and Diaphragmatic Breathing-Assisted Graded Exposure on Kinesiophobia and Anxiety During First Mobilization Among Women After Cesarean Section Eligibility criteria changed Ghadeer Fadhel AbbasNot applicable NCT07935577
  16. Notable: NIV-NAVA · Severe Bronchiolitis, a Pilot Multicenter Randomized Controlled Trial Start date pushed from Oct 2026 to Dec 1, 2026 St. Justine's HospitalNot applicable NCT07834723
  17. Notable: IVMED-85 on Pediatric Myopia Enrollment reduced: 216 → 144 participants iVeena Delivery Systems, Inc.Phase 2 NCT05761795
  18. Notable: CRF2 Agonist · Worsening Heart Failure Enrollment reduced: 300 → 210 participants Corteria PharmaceuticalsPhase 2 NCT06815471
  19. Notable: Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel · Prostate Cancer That Has Been Removed by Surgery Enrollment reduced: 612 → 175 participants NRG OncologyPhase 2/3 NCT03070886
  20. Notable: Improving Information Sharing Between Family Caregivers and Home Care Aides Enrollment reduced: 100 → 20 participants University of ConnecticutNot applicable NCT07227558
  21. Notable: Integrated Motivational Interviewing and Rational Emotive Behavior Therapy Intervention for Non-Suicidal Self-Injury Among Malaysian Primary School Students: A Feasibility Trial Protocol Enrollment reduced: 105 → 70 participants Universiti Utara MalaysiaNot applicable NCT07627061
  22. Notable: AI-Driven Multimodal Imaging Integration for Diagnosis and Prognostication of Digestive System Diseases Enrollment reduced: 5000 → 1000 participants First Affiliated Hospital, Sun Yat-Sen UniversityNot applicable NCT07087418
  23. Notable: Daraxonrasib and Daraxonrasib + GnP as First-line Treatment · Metastatic Pancreatic Adenocarcinoma Primary endpoint(s) modified Revolution Medicines, Inc.Phase 3 NCT07491445
  24. Notable: SCALE KIDS · Research Study to Look at How Well a New Medicine is at Lowering Weight · Obesity Results posted: Nov 16, 2026 Novo Nordisk A/SPhase 3 NCT04775082
  25. Notable: S243249 Monotherapy · Relapsed or Refractory Acute Leukemia With a KMT2A or NUP98 Translocation or Relapsed or Refractory AML With NPM1c Mutation Start date pushed from Oct 20, 2026 to Feb 1, 2027 ServierPhase 1/2 NCT07722312